GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS

被引:185
作者
CLARK, DWJ
机构
关键词
D O I
10.2165/00003495-198529040-00003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:342 / 375
页数:34
相关论文
共 230 条
  • [1] THE EFFECT OF ACETYLATOR PHENOTYPE ON THE DISPOSITION OF AMINOGLUTETHIMIDE
    ADAM, AM
    ROGERS, HJ
    AMIEL, SA
    RUBENS, RD
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (04) : 495 - 505
  • [2] PLASMA AND SALIVARY PHARMACOKINETICS OF DAPSONE ESTIMATED BY A THIN-LAYER CHROMATOGRAPHIC METHOD
    AHMAD, RA
    ROGERS, HJ
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) : 129 - 133
  • [3] EFFECTS OF CONCURRENT ADMINISTRATION OF OTHER SUBSTRATES OF N-ACETYLTRANSFERASE ON DAPSONE ACETYLATION
    AHMAD, RA
    ROGERS, HJ
    VANDENBURG, M
    WRIGHT, P
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (01) : 83 - 85
  • [4] DRUG-INDUCED ANTINUCLEAR ANTIBODIES AND LUPUS SYNDROMES
    ALARCONSEGOVIA, D
    [J]. DRUGS, 1976, 12 (01) : 69 - 77
  • [5] ISONIAZID ACETYLATION RATE AND DEVELOPMENT OF ANTINUCLEAR ANTIBODIES UPON ISONIAZID TREATMENT
    ALARCONSEGOVIA, D
    FISHBEIN, E
    ALCALA, H
    [J]. ARTHRITIS AND RHEUMATISM, 1971, 14 (06): : 748 - +
  • [6] ALVAN G, 1982, LANCET, V1, P333
  • [7] INTER-ETHNIC AND INTER-PHENOTYPE DIFFERENCES AMONG GHANAIANS AND CAUCASIANS IN THE METABOLIC HYDROXYLATION OF PHENYTOIN
    ANDOH, B
    IDLE, JR
    SLOAN, TP
    SMITH, RL
    WOOLHOUSE, N
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (03) : P282 - P283
  • [8] ROLE OF OXIDATION POLYMORPHISM ON BLOOD AND URINE CONCENTRATIONS OF AMITRIPTYLINE AND ITS METABOLITES IN MAN
    BALANTGORGIA, AE
    SCHULZ, P
    DAYER, P
    BALANT, L
    KUBLI, A
    GERTSCH, C
    GARRONE, G
    [J]. ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1982, 232 (03): : 215 - 222
  • [9] BATCHELOR JR, 1980, LANCET, V1, P1107
  • [10] THE DEBRISOQUINE HYDROXYLATION TEST PREDICTS STEADY-STATE PLASMA-LEVELS OF DESIPRAMINE
    BERTILSSON, L
    ABERGWISTEDT, A
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) : 388 - 390